Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer-Reference-Cited by-同舟云学术

Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer

Published:1992-02 Issue:2 Volume:3 Page:165-166
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Repetto L.,Miglietta L.,Gardin G.,Naso C.,Giudici S.,Merlini L.,Queirolo P.,Campora E.,Pronzato P.,Rosso R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/3/2/165/530965/3-2-165.pdf

Reference3 articles.

1. Salvage therapy for metastatic disease;Sedlacek;Sem in Oncol,1990

2. Mitoxantrone (M) mitomycin C (M-C) and prednisone (P) as first line chemotherapy in advanced breast cancer: A phase II study;Carmo-Pereira;Proc ASCO,1990

3. Mitomycin C (M) and mitoxantrone (MX) in chemotherapy-refractory metastatic breast cancer (C-RMBC);Santos;Proc ASCO,1990

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-Generation Process Development of Napabucasin and Impurity Control Strategy;Organic Process Research & Development;2023-05-12

2. Update on Late Relapse of Germ Cell Tumor: A Clinical and Molecular Analysis;Journal of Clinical Oncology;2003-01-01

3. Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer;Breast Cancer Research and Treatment;1997-01

4. Salvage therapies in women who fail to respond to first-line treatment with fluorouracil, epirubicin, and cyclophosphamide for advanced breast cancer.;Journal of Clinical Oncology;1994-08

5. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer;Breast Cancer Research and Treatment;1994